Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing
Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54